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Abstract
Background: The microRNA-200 family participates in the maintenance of an epithelial phenotype and loss of its expression
can result in epithelial to mesenchymal transition (EMT). Furthermore, the loss of expression of miR-200 family members is
linked to an aggressive cancer phenotype. Regulation of the miR-200 family expression in normal and cancer cells is not fully
understood.
Methodology/Principal Findings: Epigenetic mechanisms participate in the control of miR-200c and miR-141 expression in
both normal and cancer cells. A CpG island near the predicted mir-200c/mir-141 transcription start site shows a striking
correlation between miR-200c and miR-141 expression and DNA methylation in both normal and cancer cells, as determined
by MassARRAY technology. The CpG island is unmethylated in human miR-200/miR-141 expressing epithelial cells and in
miR-200c/miR-141 positive tumor cells. The CpG island is heavily methylated in human miR-200c/miR-141 negative
fibroblasts and miR-200c/miR-141 negative tumor cells. Mouse cells show a similar inverse correlation between DNA
methylation and miR-200c expression. Enrichment of permissive histone modifications, H3 acetylation and H3K4
trimethylation, is seen in normal miR-200c/miR-141-positive epithelial cells, as determined by chromatin immunoprecip-
itation coupled to real-time PCR. In contrast, repressive H3K9 dimethylation marks are present in normal miR-200c/miR-141-
negative fibroblasts and miR-200c/miR-141 negative cancer cells and the permissive histone modifications are absent. The
epigenetic modifier drug, 5-aza-29-deoxycytidine, reactivates miR-200c/miR-141 expression showing that epigenetic
mechanisms play a functional role in their transcriptional control.
Conclusions/Significance: We report that DNA methylation plays a role in the normal cell type-specific expression of miR-
200c and miR-141 and this role appears evolutionarily conserved, since similar results were obtained in mouse. Aberrant
DNA methylation of the miR-200c/141 CpG island is closely linked to their inappropriate silencing in cancer cells. Since the
miR-200c cluster plays a significant role in EMT, our results suggest an important role for DNA methylation in the control of
phenotypic conversions in normal cells.
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Introduction
miRNAs are single-stranded, 20-24 nt long RNAs that regulate
gene expression at the posttranscriptional level. miRNAs fre-
quently target 39 UTRs of mRNA, and since miRNA target motifs
do not require complete homology, hundreds of mRNA targets
may exist for each miRNA. Current estimates are that there are
nearly 900 unique miRNAs encoded in the human genome, and
these miRNAs control, in part, the expression of more than one
third of human genes [1]. A number of miRNA dysregulated in
human cancer have been shown to have oncogenic or tumor
suppressive activity [2,3,4]. These include miRNA species that
show cell type specific patterns of expression, some of which are
important in the maintenance of cell identity [5,6]. These types of
miRNA are prime targets for epigenetic control, and early studies
of miRNA control support this possibility [7,8].
miR-200c and miR-141 are members of the miR-200 family
and are important regulators of the epithelial to mesenchymal
transition (EMT) [5,9,10,11]. In addition to the role of miR-200c
and miR-141 in the phenotypic conversion of normal cells,
dysregulation of normal patterns of miR-200c expression occurs in
multiple types of cancer cells and is linked to tumor progression
[2,6,12,13,14,15]. The mechanism responsible for the control of
miR-200c expression in both normal and cancer cells is not fully
understood. In this study, we show that the epigenetic state is
closely linked to normal cell type specific expression of miR-200c
PLoS ONE | www.plosone.org 1 January 2010 | Volume 5 | Issue 1 | e8697and miR-141, and this epigenetic state is dysregulated in
carcinoma cells, where loss of miR200c/141 expression is linked
to aberrant DNA methylation and histone modifications. Finally,
we found that the miR-200c regulation by DNA methylation is
evolutionarily conserved between humans and mice. Since miR-
200c plays a significant role in EMT, our results suggest that DNA
methylation plays an important role in the control of phenotypic
conversions of normal and cancer cells.
Results and Discussion
The miR-200 family is comprised of five miRNAs that are
encoded within two clusters. Each cluster encodes a polycistronic
gene. One cluster resides on human chromosome 1 and encodes
miR-200b, miR-200a, and miR-429, while the other cluster is
located on human chromosome 12, and encodes miR-200c and
miR-141. Our small RNA library sequencing data (Figure 1A)
show that the miR-200 family is highly expressed in cultured
normal human mammary epithelial cells (HMEC) derived from
three different individuals, whereas the isogenic human mammary
fibroblast cells (FB) lack miR-200 family expression (Figure 1A). It
is apparent from the small RNA library sequencing data
(Figure 1A) that the most highly expressed members of the miR-
200 family in HMEC are miR-200c and miR-141. We
corroborated the expression of miR-200c and miR-141 in the
same set of normal mammary samples by real-time PCR, and then
expanded these results to pairs of epithelial cells and fibroblasts
from prostate and skin, as well (Figure 1B; Figure S1). In all cases,
miR-200c and miR-141 were highly expressed in epithelial cells,
but were not expressed in fibroblasts.
The mir-200c hairpin coding sequence and approximately
300 bp of upstream genomic sequence is CpG rich. According to
our calculations using the program CpG Cluster [16] this region is
a highly statistically significant CpG cluster (Figure 2A). This CpG
cluster (length 334 bp, GC% 68.56, O/E ratio 0.58, 21CpGs, p-
value 8.44610
211) has the characteristics close to a CpG island
definition based on size, GC content and CpG dinucleotide
frequency [17], as well as its location with respect to the
transcriptional unit [18]. In addition, this region is considered a
CpG island based on a recently published probabilistic definition
[19]. We analyzed this region as a possible target of epigenetic
control.
The epigenetic state of the miR-200c/141 CpG island shows
clear and extensive cell type specific differences between normal
miR-200c/141-positive and miR-200c/141-negative cells. We
used MassARRAY technology to analyze the DNA methylation
state of the mir-200c cluster CpG island (Figure 2B). Results show
that the CpG sites are unmethylated in three separate strains of
miR-200c/miR-141-positive HMEC. In contrast, all the CpG sites
are highly methylated in the isogenic miR-200c/miR-141-negative
fibroblast strains. The inverse correlation between miRNA
expression and DNA methylation extends to other miR-200c/
miR-141-positive/negative pairs of normal cells, such as prostate
epithelial cells and skin keratinocytes, and their mesenchymal cell
type counterparts, prostate and skin fibroblasts. Thus, the miR-
200c cluster CpG island is unmethylated in normal miR-200c/
miR-141-positive epithelial cells, while being densely methylated
in the paired normal miR-200c/miR-141-negative fibroblasts
(Figure 1B, Figure 2B, Figure S2).
miR-200c and miR-141 expression is lost in different types of
cancer cells [5,11,20,21], and we sought to determine if this loss of
expression was linked to epigenetic changes in the miR-200c/
miR-141 CpG island. We analyzed 11 breast cancer cell lines, and
in each case, miR-200c and miR-141 expression was closely linked
to the DNA methylation state of the CpG island (Figure 3A; Figure
S3). Seven of the breast cancer cell lines tested express miR-200c
and miR-141 and each has an unmethylated mir-200c CpG
island. The other four breast cancer cell lines tested do not express
miR-200c and miR-141 and exhibit a densely methylated mir-
200c CpG island. A similar picture emerges with respect to
prostate cancer cells. We show two prostate cancer cell lines (PC3
Figure 1. miR-200c is expressed in an epithelial selective fashion. A. miR-200 family expression according to massive parallel sequencing of
small RNA libraries from a set of three isogenic pairs of human mammary epithelial cells (HMEC) and fibroblasts (FB). The expression of the mir-200b-
200a-429 cluster located on human chromosome 1, and the expression of the mir-200c-141 cluster located on human chromosome 12 are shown.
With the average of 63,829 counts out of 3,926,984 per library in HMEC, miR-200c forms 1.625% of all small RNAs in these cells. B B. Real-time PCR
assessment of miR-200c expression in normal cell types. The left panel shows the expression of miR-200c in the same samples as panel A. The right
panel shows the expression of miR-200c in human prostate epithelial cells (PREC), prostate stromal fibroblasts (PSF), human skin keratinocytes
(Kcytes) and skin fibroblasts (HFF). The data are normalized relative to let-7a, which is expressed at equivalent levels between different samples
according to the small RNA sequencing data. Real time PCR analysis of miR-141 expression in these samples is provided in Figure S1.
doi:10.1371/journal.pone.0008697.g001
DNA Methylation of Mir-200c
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linked with aberrant DNA methylation of the mir-200c/141 CpG
island (Figure 3B; Figure S3), and two prostate cancer cell lines
(LNCaP and DU145) that retain miR-200c/miR-141 expression
and an unmethylated mir-200c/141 CpG island. Together these
results indicate that cancer cells derived from normal miR-200c/
miR-141-positive epithelial cells can replicate the cell type-specific
DNA methylation pattern of the miR-200c/141 CpG island seen
in normal miR-200c/miR-141-negative cells, and that the
aberrant DNA methylation of the miR200c/141 CpG island in
these cancer cells is associated with its transcriptional silencing in
carcinoma cells.
To demonstrate the functional significance of the epigenetic
state of the miR-200c/mir-141 CpG island in cancer cells, we
Figure 2. The mir-200c CpG island shows differential cytosine methylation between miR-200c-positive and miR-200c-negative
normal human tissues. A. A diagram of the genomic region of hsa-mir-200c. The top bar shows the specific fragments analyzed by MassARRAY.
The red fragments named with CpG sites indicate the fragments from which DNA methylation data was obtained. This data is presented panel B.
Below this is the region analyzed by MassARRAY in relation to the genomic location (in blue), followed by the region of the real-time PCR amplicon
for chromatin immunoprecipitation analysis (ChIP), and the CpG island identified by the program CpGcluster. The regions encoding the mir-200c and
mir-141 hairpins and the putative transcription start (TSS) region inferred from the human EST track of the UCSC genome browser are displayed, and
each circle on this track represents the position of a CpG dinucleotide. The ruler at the bottom shows the location on human chromosome 12
according to human genome assembly hg18. B B. Summary of 5-methylcytosine levels obtained by MassARRAY analysis of the hsa-mir-200c CpG island
in samples characterized in Figure 1B. The y-axis shows the percent of cytosine methylation within the individual CpG units marked on x-axis. The
CpG units within the MassARRAY amplicon are numbered in the reverse direction, with CpG 2 being located within the miR-200c coding sequence.
doi:10.1371/journal.pone.0008697.g002
DNA Methylation of Mir-200c
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methyltransferase inhibitor 5-aza-29-deoxycytidine (5-AdC). The
miR-200c/miR-141-negative breast cancer cell lines MDA-MB-
231 and BT549 and prostate cancer cell line PC3 were treated
with 3 mM 5-AdC for 96 h and miR-200c/141 expression was
assessed by real-time PCR. Figure 4 shows 5-AdC reactivated
miR-200c expression in all three cancer cell lines. The level of
miR-200c increased 4.3-fold in MDA-MB-231 (p-value=0.0004),
6.4-fold in BT549 (p-value=0.0107) and 4.2-fold in PC3 cells (p-
value=0.0072). A similar reactivation of miR-141 expression (p-
value,0.01) was also observed in these cancer cell lines after 5-
AdC treatment (Figure S4). These data suggest that epigenetic
mechanisms participate in the inappropriate repression of miR-
200c/miR-141 expression in cancer cells.
The histone modification state of the mir-200c cluster CpG
island also shows cell type-specific differences that are closely
linked to the expression state of miR-200c/141 in normal and
cancer cells. Figure 5 shows the results of chromatin immunopre-
cipitations coupled to quantitative real-time PCR analysis that
were used to examine the histone modification state of the miR-
200c/141 CpG island in normal and cancer cells. The CpG island
of mir-200c/141 in the three different strains of miR-200c/miR-
141-positive HMEC exists in a transcriptionally competent state; it
is enriched for the transcriptionally permissive modifications of
histone H3 acetylation (H3Ac) and lysine 4 trimethylation
(H3TriMeK4), while the transcriptionally repressive histone mark
of histone H3 lysine 9 dimethylation (H3DiMeK9) is underrep-
resented (Figure 5). In contrast, in the isogenic miR-200c/miR-
141-negative mammary fibroblasts permissive histone modifica-
tions are absent, and the repressive H3 lysine 9 dimethylation
mark is present (Figure 5). Similarly, the breast cancer cell lines
Figure 3. DNA methylation of mir-200c CpG island in breast
and prostate cancer cell lines. A. miR-200c expression and mir-200c
CpG island methylation in eleven breast cancer cell lines. B. miR-200c
expression and mir-200c CpG island methylation in four prostate cancer
cell lines. The top panel of each figure shows the expression of miR-
200c in cancer samples as detected by real-time PCR, normalized to let-
7a. The bottom panel shows the methylation level of the mir-200c CpG
island region in the same cancer samples. The level of methylation of
individual CpG units within the MassARRAY amplicon is displayed as a
heatmap with the lowest methylation in yellow and the highest
methylation in blue. The y-axis marks the individual CpG units.
doi:10.1371/journal.pone.0008697.g003
Figure 4. 5-aza-29-deoxycytidine treatment reactivates miR-
200c expression in breast and prostate cancer cell lines. Cells
were treated with 3 mM 5-aza-29-deoxycytidine for 96 h. The level of
expression of miR-200c was measured by real-time PCR. The average of
4 independent samples is displayed, the error bars show the standard
error of measurement. The values were normalized to untreated
controls (100%). Figure S4 shows the 5-aza-29-deoxycytidine-mediated
reactivation of miR-141 in the same samples.
doi:10.1371/journal.pone.0008697.g004
Figure 5. The histone modification state of the mir-200c CpG
island. Permissive histone marks represented by acetylation of histone
H3 (H3Ac) and trimethylation of lysine 4 of histone H3 (H3TriMeK4) as
well as the repressive histone mark dimethylation of lysine 9 of histone
H3 (H3diMeK9) were analyzed using chromatin immunoprecipitation
coupled to real-time PCR of the region described in Figure 2A. HMEC
samples are shown in green, isogenic FB samples are shown in red, and
two miR-200-negative breast cancer cell lines are in blue. The y-axis
shows fold enrichment of each histone mark over input DNA within the
mir-200c CpG island.
doi:10.1371/journal.pone.0008697.g005
DNA Methylation of Mir-200c
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and K4 trimethylation and acquired a repressive histone state,
enriched for the H3 lysine 9 dimethylation mark (Figure 5). No
enrichment of trimethylation of histone H3 lysine 27 was detected
in the miR-200c/141 CpG island in the samples analyzed (Figure
S5). Taken together, the results from the analyses of miR-200c/
141 expression, DNA methylation, and histone modification states
across a variety of normal and cancer cell types demonstrate a
close link between the expression of mir-200c/141 and the
epigenetic state of their associated CpG island.
Finally, we sought to determine if the epigenetic regulation of
miR-200c expression in normal cells is conserved evolutionarily,
reasoning that DNA methylation-linked control of miR-200c
expression across mammalian species would provide further
experimental support for epigenetic control of cell-type specific
expression of miR-200c. The whole genomic cluster containing
mir-200c and mir-141 is well conserved between the human and
mouse genome. Similar to the human mir-200c/141 genomic
region, the mouse mir-200c/141 genomic region also contains a
CpG island (Figure 6A; length 325 bp, GC% 66.77, O/E ratio
0.58, 19 CpGs, p-value 1.06610
210). To evaluate a potential role
for DNA methylation in the control of miR-200c/141 in mice,
CpG methylation and miRNA expression were analyzed in mouse
epithelial cells (epidermis of SKH-1 mouse and keratinocyte cell
lines 308 and 6R90) and mouse fibroblasts (cell lines NIH 3T3,
NIH 3T6, and NR6). A MassARRAY amplicon was designed to
analyze the DNA methylation state of the mouse mir-200c/141
region homologous to that analyzed in human (Figure 6A).
Strikingly similar results for miR-200c were found between the
human cells and mouse cells. Mouse keratinocytes expressed
significant levels of miR-200c, while the mouse fibroblasts did not
express detectable levels of miR-200c (Figure 6B). DNA
methylation analysis by MassARRAY revealed that the miR-
200c-positive keratinocytes showed minimal DNA methylation in
the mir-200c CpG island, while the miR-200c-negative mouse
fibroblasts showed extensive DNA methylation of all CpG sites in
the region (Figure 6B). The significant conservation in DNA
sequence, patterns of cell type-specific DNA methylation, and the
associated miR-200c expression patterns between the human and
mouse genomes, which are separated by 75 million years of
evolution [22], provides evidence that epigenetic mechanisms play
a functional role in the control of miR-200c expression.
In summary, our findings provide multiple lines of evidence that
epigenetic mechanisms are involved in the regulation of miR-
200c/141 expression in both normal and cancer cells. First, there
is a consistent inverse correlation between expression and DNA
methylation states in normal human and mouse cell types, as well
as human breast and prostate cancer cell lines. Second, different
histone codes exist between miR-200c/141 expressing and non-
expressing cells that accurately mirror the expression and DNA
methylation states. Third, the epigenetic modifier 5-aza-29-
deoxycytidine relieves the repression of miR-200c/miR-141 in
cancer cell lines. Fourth, the link between DNA methylation and
expression states occurs across mammalian species, since it is seen
in human and mouse. Taken together, these findings indicate that
miR-200c/141 is an evolutionarily conserved epigenetically labile
miRNA cluster.
Dysregulation of miR-200c and miR-141 occurs in multiple
cancer types [5,11,20,21,23,24,25,26], and this dysregulation
involves a compromise of the epigenetic state of the CpG island
associated with miR-200c and miR141. Results suggest that these
carcinoma cells may co-opt de novo DNA methylation pathways
involved in the epigenetic control of normal cell type-specific
genes, such as those that govern the epigenetic state of miR-200c/
miR-141. A similar apparent co-option of cell type specific DNA
methylation pathways by cancer cells is also seen in protein-coding
genes, such as maspin and 14-3-3 sigma [27,28]. Together these
results suggest that pathways responsible for the establishment or
maintenance of normal cell type-specific DNA methylation states
may be disrupted during carcinogenesis.
Since miR-200c and miR141 play an important role in EMT
and therefore cell identity, disruption of mechanisms that govern
cell type specific DNA methylation patterns during carcinogenesis
could likely effect expression of miR-200c and miR141 and
provide phenotypic plasticity to cancer cells. Support of this
possibility comes from the phenotypes of the cancer cells analyzed
in this study. All four of the breast cancer cell lines that lost
miR-200c and miR-141 expression have an aberrantly methylated
mir-200c/141 CpG island, and each of these cell lines displays a
mesenchymal phenotype [11,29]. In contrast, those breast cancer
cell lines that express miR-200c and miR-141 and have an
unmethylated CpG island display an epithelial phenotype [11,29].
A similar picture emerges in the prostate cancer cell lines. The
Figure 6. Epigenetic control of miR-200c expression is evolu-
tionarily conserved. A. Diagram of the mouse mmu-mir-200c
genomic interval. The top bar shows the area analyzed by MassARRAY.
The regions encoding the hairpins of mir-200c and mir-141 and the
putative transcription start (TSS) inferred from the mouse EST track
displayed on the UCSC genome browser are shown, and each circle on
this track represents the location of a CpG dinucleotide. Similar to the
human hsa-mir-200c, the mouse mmu-mir-200c contains a CpG island,
identified by the program CpG Cluster. The ruler at the bottom shows
the location on mouse chromosome 6 according to genome assembly
mm9. The genes are encoded on the (-) strand. B. Mouse cells show a
similar cell type specific pattern in miR-200c expression to human cells
and this expression is linked to the DNA methylation state of the CpG
island. The left panel shows the expression of miR-200c in mouse
epithelial cells (308, 6R90, SKH-1 epidermis) and mouse fibroblast cell
lines (NIH 3T3, NR6, NIH 3T6) as detected by real-time PCR. The right
panel shows the methylation level of the mir-200c CpG island region in
the same mouse samples. The level of methylation of individual CpG
units within the MassARRAY amplicon is displayed as a heatmap with
the lowest methylation in yellow and the highest methylation in blue.
The x-axis marks the individual CpG units. CpG units within MassARRAY
amplicon are numbered in reverse direction, with CpG 1 being located
within the miR-200c coding sequence.
doi:10.1371/journal.pone.0008697.g006
DNA Methylation of Mir-200c
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display an aberrantly methylated CpG island and a mesenchymal
phenotype, whereas LnCaP and Du145 retain miR-200c and
miR-141 expression and an epithelial phenotype [11,30]. These
results suggest that DNA methylation may control the phenotypic
changes observed in cancer cells.
Materials and Methods
Cell lines and cell culture
Finite lifespan pre-stasis HMEC from specimens 184 (batch D),
48R (batch T), and 240L (batch B), were derived from reduction
mammoplasty tissue of women aged 21, 16, and 19 respectively.
Cells were initiated as organoids in primary culture in serum-
containing M85 medium supplemented with oxytocin (Bachem) at
0.1 nM, and maintained in M87A medium supplemented with
oxytocin and cholera toxin at 0.5 ng/ml [31]. Fibroblasts from
specimens 184, 48, and 240 L were obtained from the same
reduction mammoplasty tissue and were grown in DMEM/F12
with 10% FBS and 10 mg/ml insulin [31] and further propagated
in DMEM/F12 with 10% FBS. Prostate epithelial cells were
obtained from Clonetics (San Diego, CA), and fetal skin
keratinocytes from Cell Applications (San Diego, CA.) and were
grown according to the suppliers instructions. Human foreskin
fibroblasts (HFFs) were maintained and cultured by the Arizona
Cancer Center Cell Culture Shared Service. Human prostate
stromal fibroblasts (PSF) were were cultured as previously
described [32]. Breast cancer cell lines BT549, HS578T, MCF7,
MDA-MB-157, MDA-MB-231, MDA-MB-453, MDA-MB-468,
UACC893, UACC1179, UACC2087, and UACC3199 were
cultured as previously described [33,34]. Prostate cancer cell lines
PC3, PC3 B1, LNCaP, and DU145 [35,36,37] were maintained in
RPMI 1640 medium containing 10% fetal bovine serum
supplemented with 100 units/ml penicillin and 50 mg/ml strepto-
mycin. Mouse keratinocyte cell lines 308 and 6R90 were cultured
as described [38], mouse fibroblast cell lines NIH 3T3, NIH 3T6
and NR6 [39,40,41] were maintained in DMEM medium
containing 10% fetal bovine serum. SKH-1 mouse epidermis
samples were removed from liquid nitrogen snap frozen dorsal
skin by scraping on dry ice.
miRNA library preparation, sequencing and analysis
Total RNA was extracted using Trizol. The small RNA fraction
was purified on a 15% polyacrylamide-urea gel. A preadenylated
adaptor was ligated to the 39 end of the small RNA followed by
purification of the ligation product on a 15% PAA-urea gel. An
Illumina specific 59 adaptor was ligated and the product was
purified on a 10% PAA-urea gel. Small RNA with ligated adaptors
was reverse transcribed into DNA using a RT primer with
Illumina specific extension. cDNA was then PCR amplified using
Illumina specific primers and the PCR product was purified on a
3% agarose gel. Small RNA libraries were submitted for Illumina
sequencing to NCGR (Santa Fe, NM). Reads from Illumina GAII
were mapped to the hg18 human genome assembly using program
Novoalign (www.novocraft.com). Output from Novoalign was
further analyzed in R (http://www.r-project.org). The counts of
individual miRNAs were normalized for average library size
(3,926,984 counts).
Nucleic acid isolation
RNA was isolated using either Trizol (Invitrogen) or the RNeasy
Mini kit (Qiagen) and quantified by absorption measurements at
260 nm. Genomic DNA was isolated using the DNeasy Blood and
Tissue Kit (Qiagen) and quantified spectrophotometrically.
Real-time PCR detection of miRNA
Real-time PCR detection of microRNAs was performed in
principle as described [42]. Reverse transcription was performed
using TaqMan Reverse Transcription Reagents (Applied Biosys-
tems, Foster City, CA, USA). Real-time PCR was conducted on
an ABI Prism 7500 Sequence Detection System (Applied
Biosystems, Foster City, CA, USA) using PerfeCta SYBR Green
SuperMix, Low ROX (Quanta Biosciences, Gaithersburg, MD,
USA) with a 95uC denaturation for 3 minutes followed by 40
cycles of 95uC for 15 seconds and 60uC for 45 seconds. Differences
in expression were determined using the comparative Ct method
described in the ABI user manual relative to let-7a. Primer
sequences are listed in Table S1.
CpG island prediction
CpG islands were predicted using the program CpGcluster [16].
This program uses a statistical approach to search for regions with
significant enrichment of CpG dinucleotides rather than param-
eters within a sliding window. We set the threshold to 50 (median
distance) and p-value cut to 10
28.
DNA methylation analysis by MassARRAY
DNA methylation analysis by MassARRAY was performed as
described [43]. Primer sequences are listed in Table S1.
5-aza-29-deoxycytidine treatment
Cells were treated with 3 mM 5-aza-29-deoxycytidine (Sigma, St
Louis, MO, USA) for 96 h, as previously described [44].
Chromatin immunoprecipitation
Chromatin immoprecipitation (ChIP) analysis was performed as
described previously [33,45,46] with antibodies against acetylated
histone H3 (#06-599, Millipore), trimethylated histone H3 K4
(#05-745, Upstate), dimethylated histone H3 K9 (CS200587,
Millipore), and trimethylated histone H3 K27 (#07-449, Milli-
pore). Equal amounts (1 ng) of ChIP and input DNA were used for
real-time PCR analysis. Primers were designed for use with the
Human Universal Probe Library Set (Roche Diagnostics,
Indianapolis, IN, USA). Real-time PCR was conducted on an
ABI Prism 7500 Sequence Detection System (Applied Biosystems,
Foster City, CA, USA) using PerfeCta qPCR SuperMix, Low
ROX (Quanta Biosciences, Gaithersburg, MD, USA) with a 95uC
denaturation for 3 minutes followed by 40 cycles of 95uC for 15
seconds and 60uC for 45 seconds. Primer sequences are listed in
Table S1.
Supporting Information
Figure S1 Real-time PCR assessment of miR-141 expression in
normal cell types. The left panel shows the expression of miR-141
in three isogenic pairs of mammary epithelial cells (HMEC) and
mammary fibroblasts (FB). The right panel shows the expression of
miR-141 in human prostate epithelial cells (PREC), prostate
stromal fibroblasts (PSF), human skin keratinocytes (Kcytes) and
skin fibroblasts (HFF). The data are normalized relative to let-7a,
which is expressed at consistent levels between different samples
according to the small RNA sequencing data.
Found at: doi:10.1371/journal.pone.0008697.s001 (0.13 MB TIF)
Figure S2 DNA methylation of the mir-200c CpG island
inversely correlates with miR-200c expression in normal human
samples. This figure summarizes data shown in Figure 1B and 2B.
The upper panel shows the expression of miR-200c detected by
real-time PCR. The bottom panel shows the methylation level of
DNA Methylation of Mir-200c
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level of methylation of individual CpG units within the
MassARRAY amplicon is displayed as a heatmap with the lowest
methylation in yellow and the highest methylation in blue. The y-
axis marks the individual CpG units.
Found at: doi:10.1371/journal.pone.0008697.s002 (0.19 MB TIF)
Figure S3 Real-time PCR assessment of miR-141 expression in
breast and prostate cancer cell lines. The left panel shows the
expression of miR-141 in eleven human breast cancer cell lines.
The right panel shows the expression of miR-141 in four human
prostate cancer cell lines.
Found at: doi:10.1371/journal.pone.0008697.s003 (0.14 MB TIF)
Figure S4 miR-141 expression in cancer cell lines is reactivated
by 5-aza-29-deoxycytidine treatment. Cells were treated with
3 mM 5-AdC for 96 h. The level of expression of miR-141 was
measured by real-time PCR. The average of 4 measurements is
displayed, the error bars show the standard error of measurement.
The values were normalized to untreated controls (100%).
Found at: doi:10.1371/journal.pone.0008697.s004 (0.06 MB TIF)
Figure S5 Histone H3 K27 trimethylation state of the mir-200c
CpG island. Histone H3 lysine 27 trimethylation levels of the
region of the mir-200c CpG island described in Figure 2A were
analyzed by chromatin immunoprecipitation coupled to real-time
PCR. Epithelial cells (HMEC) are shown in green and their
isogenic fibroblasts (FB) are shown in red. The y-axis shows a lack
of enrichment of the histone H3 K27 trimethylation mark within
the mir-200c CpG island relative to input DNA in all the samples
analyzed.
Found at: doi:10.1371/journal.pone.0008697.s005 (0.08 MB TIF)
Table S1 List of primer sequences used in the study
Found at: doi:10.1371/journal.pone.0008697.s006 (0.03 MB
PDF)
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